The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Atacand 4 mg tablets

4 milligram(s) Tablet

CHEPLAPHARM Arzneimittel GmbHPA2239/010/001

Main Information

Trade NameAtacand 4 mg tablets
Active SubstancesCandesartan cilexetil
Strength4 milligram(s)
Dosage FormTablet
Licence HolderCHEPLAPHARM Arzneimittel GmbH
Licence NumberPA2239/010/001

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA06 candesartan


Licence Issued29/04/2002
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListCandesartan 4mg Tablets
Interchangeable List CodeIC0009-008-002
Interchangeable List DocumentPDF of Interchangeable List
« Back